Search

Hope A. Robinson

Examiner (ID: 16251, Phone: (571)272-0957 , Office: P/1652 )

Most Active Art Unit
1652
Art Unit(s)
1653, 1652, 1656
Total Applications
1881
Issued Applications
1007
Pending Applications
292
Abandoned Applications
622

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7710169 [patent_doc_number] => 20120003204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANDER' [patent_app_type] => utility [patent_app_number] => 13/225317 [patent_app_country] => US [patent_app_date] => 2011-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9685 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13225317 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/225317
Composition containing arazyme for the prevention and treatment of cancer Sep 1, 2011 Issued
Array ( [id] => 7808194 [patent_doc_number] => 20120059148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE' [patent_app_type] => utility [patent_app_number] => 13/214862 [patent_app_country] => US [patent_app_date] => 2011-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12984 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20120059148.pdf [firstpage_image] =>[orig_patent_app_number] => 13214862 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/214862
NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE Aug 21, 2011 Abandoned
Array ( [id] => 8430858 [patent_doc_number] => 20120252732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'ALBUMIN FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/212879 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 115829 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212879 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/212879
ALBUMIN FUSION PROTEINS Aug 17, 2011 Abandoned
Array ( [id] => 17156443 [patent_doc_number] => 20210317494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Liquor And Uses Thereof [patent_app_type] => utility [patent_app_number] => 13/814912 [patent_app_country] => US [patent_app_date] => 2011-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62679 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814912 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/814912
Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Liquor And Uses Thereof Aug 4, 2011 Abandoned
Array ( [id] => 10857775 [patent_doc_number] => 08883970 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Alpha-amylase variants' [patent_app_type] => utility [patent_app_number] => 13/187014 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 86772 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187014 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/187014
Alpha-amylase variants Jul 19, 2011 Issued
Array ( [id] => 9166503 [patent_doc_number] => 08592180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Botryoccocus braunii triterpene synthase proteins and nucleic acid molecules, and methods for their use' [patent_app_type] => utility [patent_app_number] => 13/186185 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 14017 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13186185 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/186185
Botryoccocus braunii triterpene synthase proteins and nucleic acid molecules, and methods for their use Jul 18, 2011 Issued
Array ( [id] => 9496724 [patent_doc_number] => 08735540 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-27 [patent_title] => 'Peptides with sequentially arranged streptavidin binding modules' [patent_app_type] => utility [patent_app_number] => 13/185070 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 10980 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13185070 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/185070
Peptides with sequentially arranged streptavidin binding modules Jul 17, 2011 Issued
Array ( [id] => 9937154 [patent_doc_number] => 08986960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Microorganisms with extended substrate utilization range' [patent_app_type] => utility [patent_app_number] => 13/183638 [patent_app_country] => US [patent_app_date] => 2011-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 22273 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183638 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/183638
Microorganisms with extended substrate utilization range Jul 14, 2011 Issued
Array ( [id] => 7742141 [patent_doc_number] => 20120020911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'MATRIX COMPOSED OF A NATURALLY-OCCURRING PROTEIN BACKBONE CROSS LINKED BY A SYNTHETIC POLYMER AND METHODS OF GENERATING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 13/181562 [patent_app_country] => US [patent_app_date] => 2011-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 29263 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020911.pdf [firstpage_image] =>[orig_patent_app_number] => 13181562 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/181562
Pegylated fibrinogen precursor molecule Jul 12, 2011 Issued
Array ( [id] => 12247556 [patent_doc_number] => 09920323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'Genetically modified phage and use thereof' [patent_app_type] => utility [patent_app_number] => 13/178402 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12993 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178402 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/178402
Genetically modified phage and use thereof Jul 6, 2011 Issued
Array ( [id] => 7567078 [patent_doc_number] => 20110287141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'CLONING, EXPRESSION AND USE OF ACID PHOSPHOLIPASES' [patent_app_type] => utility [patent_app_number] => 13/171005 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13868 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287141.pdf [firstpage_image] =>[orig_patent_app_number] => 13171005 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/171005
Phospholipase polypeptide and a DNA encoding same Jun 27, 2011 Issued
Array ( [id] => 7579903 [patent_doc_number] => 20110293786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Phospholipase C enzyme' [patent_app_type] => utility [patent_app_number] => 13/134964 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12492 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20110293786.pdf [firstpage_image] =>[orig_patent_app_number] => 13134964 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/134964
Phospholipase C enzyme Jun 21, 2011 Abandoned
Array ( [id] => 8566559 [patent_doc_number] => 20120329131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'METHOD FOR INCREASING THE ACTIVITY OF SUPEROXIDE DISMUTASE' [patent_app_type] => utility [patent_app_number] => 13/166402 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4016 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166402 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/166402
METHOD FOR INCREASING THE ACTIVITY OF SUPEROXIDE DISMUTASE Jun 21, 2011 Abandoned
Array ( [id] => 7744261 [patent_doc_number] => 20120021985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'ALBUMIN FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/152677 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 128976 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20120021985.pdf [firstpage_image] =>[orig_patent_app_number] => 13152677 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/152677
ALBUMIN FUSION PROTEINS Jun 2, 2011 Abandoned
Array ( [id] => 9254431 [patent_doc_number] => 08617842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Enzymes for use in enzymatic bleaching of food products' [patent_app_type] => utility [patent_app_number] => 13/067476 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13643 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13067476 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/067476
Enzymes for use in enzymatic bleaching of food products Jun 2, 2011 Issued
Array ( [id] => 7756697 [patent_doc_number] => 20120028900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'METHOD OF PRODUCING FACTOR VIII PROTEINS BY RECOMBINANT METHODS' [patent_app_type] => utility [patent_app_number] => 13/153040 [patent_app_country] => US [patent_app_date] => 2011-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 27108 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028900.pdf [firstpage_image] =>[orig_patent_app_number] => 13153040 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/153040
METHOD OF PRODUCING FACTOR VIII PROTEINS BY RECOMBINANT METHODS Jun 2, 2011 Abandoned
Array ( [id] => 7510892 [patent_doc_number] => 20110256620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'NUCLEIC ACID ENCODING A SELF-ASSEMBLING SPLIT-FLUORESCENT PROTEIN SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/118174 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 27800 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256620.pdf [firstpage_image] =>[orig_patent_app_number] => 13118174 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/118174
Nucleic acid encoding a self-assembling split-fluorescent protein system May 26, 2011 Issued
Array ( [id] => 8289285 [patent_doc_number] => 20120177610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins' [patent_app_type] => utility [patent_app_number] => 13/114951 [patent_app_country] => US [patent_app_date] => 2011-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 17658 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 83 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114951 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/114951
Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins May 23, 2011 Abandoned
Array ( [id] => 8684431 [patent_doc_number] => 20130052715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'METHOD FOR PRODUCING RECOMBINANT THROMBIN' [patent_app_type] => utility [patent_app_number] => 13/641844 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5627 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641844 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/641844
METHOD FOR PRODUCING RECOMBINANT THROMBIN Apr 19, 2011 Abandoned
Array ( [id] => 8490057 [patent_doc_number] => 20120289464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'ANGIOGENICALLY EFFECTIVE UNIT DOSE OF FGF-2 AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 13/088132 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16627 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13088132 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/088132
Method of treating coronary artery disease FGF-2 Apr 14, 2011 Issued
Menu